Guest guest Posted October 30, 2001 Report Share Posted October 30, 2001 In a message dated 10/29/2001 9:40:11 PM Pacific Standard Time, rick@... writes: > So here's our challenge. Can the help find a researcher who > wants to snag some Muscular Dystrophy Association funds to develop a > therapy for CMT? From the current issue of QUEST, the monthly > magazine of the MDA: Umm What about Doctor Shy in Michigan???? jenny Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 30, 2001 Report Share Posted October 30, 2001 So here's our challenge. Can the help find a researcher who wants to snag some Muscular Dystrophy Association funds to develop a therapy for CMT? From the current issue of QUEST, the monthly magazine of the MDA: As knowledge about the genetic causes of Charcot-Marie-Tooth disease (CMT) grows, MDA is encouraging researchers to translate that knowledge into treatment strategies. MDA-funded researchers have been sorting through a maze of CMT types, each one cause by a distinct genetic defect. To date, they've uncovered clues to nearly 20 CMT-linked genes, and identified nine of them. All types of CMT cause breakdown of the peripheral nerves, leading to weakness and sensory loss in the extremities. The nine discovered genes - essential to the axons (the " wires " inside the nerves), or myelin (the insulation around the wires) - have helped unravel steps in that disease process. " MDA funds are availalbe for projects that have the clear goal of developing a therapy for any form of CMT, " MDA Director of Research Development Sharon Hesterlee announced in a recent briefing to past and present MDA grantees. " Such projects may involve gene transfer, stem cells or drug interventions, and will be given high-priority status during the evaluation process. " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.